フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Canopus BioPharma, Inc. (OTC:CBIA); (www.canopusbiopharma.com) today announced that it has successfully completed the second...
LOS ANGELES, California and GUANGZHOU, China, August 12 /PRNewswire-FirstCall/ -- - Major Threat Treatable With StatC(TM); FDA-Approved Drugs to...
Canopus BioPharma, Inc. (OTC: CBIA), is pleased to announce that the South African Medicines Control Council has granted approval...
Canopus BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy of its oncology candidate, CB1400, as a tumor reducing agent and...
LOS ANGELES, California, June 18 /PRNewswire-FirstCall/ -- Canopus BioPharma, Inc. (OTC:CBIA), a biotechnology company developing pharmaceutical...
Canopus BioPharma, Inc. (OTC: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients...
Canopus BioPharma, Inc. (OTCPK: CBIA), a biotechnology company developing pharmaceutical products and assay methods for patients...
Drake Holding Corp. (DRKH.PK) announced that its corporate name has been officially changed to Canopus BioPharma, Inc. and, to...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約